Ashland Inc. (ASH) shares have surged 30.2% over the past six months, significantly outperforming its industry. The rally is driven by improved margin resilience from cost reductions and portfolio optimization, strong free cash flow generation of $103 million, and a doubled $1 billion share buyback authorization. The company's shift to a business-unit-focused operating model supports profitable growth in specialty chemicals.

Ashland Inc. is improving its specialty chemicals portfolio through cost reductions and operational efficiency, generating $103 million in Q3 free cash flow and approving a $1 billion share repurchase program. However, the company faces headwinds from weak industrial demand, logistics pressures, tariffs (approximately $70 million impact expected), and concentration risk in consumer-oriented businesses. ASH stock has gained 37.5% over the past year but carries a Zacks Rank #3 (Hold) rating.

Ashland Inc. will host an Innovation Day webcast on September 17, 2026, to present updates on its Technology Platforms, commercial progress, and scalability. The event will feature presentations from company executives and senior technology leaders discussing innovations and commercial opportunities across key markets. A live Q&A session will follow the formal remarks, with the webcast available for replay.

The global pharmaceutical surfactants market was valued at USD 4.5 billion in 2025 and is projected to reach USD 6.93 billion by 2035, growing at a CAGR of 4.42%. The market is driven by increasing demand for improved drug formulation, delivery systems, and expanding healthcare infrastructure. Non-ionic surfactants currently hold the largest market share, while Asia-Pacific is expected to be the fastest-growing region.

Ashland Inc. issued a statement responding to an investor presentation by Ancora Alternatives LLC, reaffirming its commitment to shareholder value creation and its growth strategies. The company stated it intends to engage constructively with Ancora despite the activist investor not engaging prior to its presentation. Ashland's Board continues to evaluate strategy and capital allocation regularly.

The Schall Law Firm is investigating Ashland Inc. (NYSE: ASH) for potential securities law violations related to allegedly false or misleading statements. Ashland reported Q2 2026 results that missed analyst estimates, citing operational challenges at its Hopewell manufacturing facility, softer energy demand due to Middle East conflict, and reduced EV-driven demand. The stock fell 13.8% following the announcement.

Ashland Inc. (NYSE:ASH) announced a quarterly cash dividend of $0.42 per share, representing a 1.2% increase from the previous quarter. The dividend will be paid on June 15, 2026, to shareholders of record as of June 1, 2026. The company had 45,788,007 shares outstanding as of April 30, 2026.

The global nutraceutical excipients market is expected to grow at a CAGR of 7.4% from 2025 to 2030, driven by rising consumer demand for dietary supplements, functional foods, and wellness products. Coating agents and modified-release technologies are leading growth segments, while Asia Pacific emerges as the fastest-growing region. Major industry players are investing in clean-label, plant-based, and sustainable formulation solutions.

The global unsaturated polyester resin market is projected to grow from USD 14.98 billion in 2025 to USD 33.40 billion by 2035, with a CAGR of 8.35%. Asia Pacific dominates with 59.31% volume share, driven by rapid urbanization, lightweight material demand, and renewable energy expansion. Key growth drivers include construction, automotive, and marine applications, while sustainability focus and AI-driven innovations shape the industry's future.

Ashland Inc. (NYSE:ASH) announced that its board of directors has declared a quarterly cash dividend of $0.415 per share on common stock, payable on March 15, 2026, to shareholders of record as of March 1, 2026. The company had 45,762,391 shares outstanding as of December 31, 2025.

The global food thickeners market is projected to grow from USD 20.04 billion in 2026 to USD 35.02 billion by 2035, at a CAGR of 6.4%. Growth is driven by increasing demand for clean-label ingredients, plant-based products, and functional foods. North America currently leads the market with 41% share, while Asia Pacific is the fastest-growing region. Hydrocolloids dominate by type, and beverages lead by application, with sauces and dips expected to grow fastest.

Stock markets experienced a mixed day with major indexes declining, while individual stocks showed significant movements. Healthcare and technology stocks saw notable performance changes, with some companies experiencing substantial gains or losses.